160 related articles for article (PubMed ID: 33023437)
21. Recombinant immunotoxins in targeted cancer cell therapy.
Reiter Y
Adv Cancer Res; 2001; 81():93-124. PubMed ID: 11430597
[TBL] [Abstract][Full Text] [Related]
22. Human toxin-based recombinant immunotoxins/chimeric proteins as a drug delivery system for targeted treatment of human diseases.
Lorberboum-Galski H
Expert Opin Drug Deliv; 2011 May; 8(5):605-21. PubMed ID: 21453191
[TBL] [Abstract][Full Text] [Related]
23. Hosts and Heterologous Expression Strategies of Recombinant Toxins for Therapeutic Purposes.
di Leandro L; Colasante M; Pitari G; Ippoliti R
Toxins (Basel); 2023 Dec; 15(12):. PubMed ID: 38133203
[TBL] [Abstract][Full Text] [Related]
24. Immunotoxin: A new tool for cancer therapy.
Allahyari H; Heidari S; Ghamgosha M; Saffarian P; Amani J
Tumour Biol; 2017 Feb; 39(2):1010428317692226. PubMed ID: 28218037
[TBL] [Abstract][Full Text] [Related]
25. Recombinant immunotoxins for the treatment of haematological malignancies.
Kreitman RJ
Expert Opin Biol Ther; 2004 Jul; 4(7):1115-28. PubMed ID: 15268678
[TBL] [Abstract][Full Text] [Related]
26. Prospects of bacterial and plant protein-based immunotoxins for treatment of cancer.
Weidle UH; Tiefenthaler G; Schiller C; Weiss EH; Georges G; Brinkmann U
Cancer Genomics Proteomics; 2014; 11(1):25-38. PubMed ID: 24633317
[TBL] [Abstract][Full Text] [Related]
27. Immunotoxins and cytokine toxin fusion proteins.
Strom TB; Anderson PL; Rubin-Kelley VE; Williams DP; Kiyokawa T; Murphy JR
Semin Immunol; 1990 Nov; 2(6):467-79. PubMed ID: 2104283
[TBL] [Abstract][Full Text] [Related]
28. Immunotoxins in the treatment of hematologic malignancies.
Kreitman RJ; Pastan I
Curr Drug Targets; 2006 Oct; 7(10):1301-11. PubMed ID: 17073592
[TBL] [Abstract][Full Text] [Related]
29. Targeted therapy of cancer using diphtheria toxin-derived immunotoxins.
Potala S; Sahoo SK; Verma RS
Drug Discov Today; 2008 Sep; 13(17-18):807-15. PubMed ID: 18678276
[TBL] [Abstract][Full Text] [Related]
30. Therapeutic potential of anticancer immunotoxins.
Choudhary S; Mathew M; Verma RS
Drug Discov Today; 2011 Jun; 16(11-12):495-503. PubMed ID: 21511052
[TBL] [Abstract][Full Text] [Related]
31. Diphtheria toxin-based targeted toxin therapy for brain tumors.
Li YM; Vallera DA; Hall WA
J Neurooncol; 2013 Sep; 114(2):155-64. PubMed ID: 23695514
[TBL] [Abstract][Full Text] [Related]
32. Drug targeting with monoclonal antibodies. A review.
Blakey DC
Acta Oncol; 1992; 31(1):91-7. PubMed ID: 1637417
[TBL] [Abstract][Full Text] [Related]
33. [Recombinant immunotoxins and chimeric toxins for targeted therapy in oncology].
Chiron MF
Bull Cancer; 1997 Dec; 84(12):1135-40. PubMed ID: 9587366
[TBL] [Abstract][Full Text] [Related]
34. From immunotoxins to immunoRNases.
De Lorenzo C; D'Alessio G
Curr Pharm Biotechnol; 2008 Jun; 9(3):210-4. PubMed ID: 18673286
[TBL] [Abstract][Full Text] [Related]
35. Immunotoxins.
Kreitman RJ
Expert Opin Pharmacother; 2000 Sep; 1(6):1117-29. PubMed ID: 11249483
[TBL] [Abstract][Full Text] [Related]
36. Immunotoxins and cytokine toxin fusion proteins.
Strom TB; Anderson PL; Rubin-Kelley VE; Williams DP; Kiyokawa T; Murphy JR
Ann N Y Acad Sci; 1991 Dec; 636():233-50. PubMed ID: 1793213
[TBL] [Abstract][Full Text] [Related]
37. Recombinant fusion toxins for cancer treatment.
Kreitman RJ
Expert Opin Biol Ther; 2002 Dec; 2(8):785-91. PubMed ID: 12517258
[No Abstract] [Full Text] [Related]
38. Increasing anticarcinoma activity of an anti-erbB2 recombinant immunotoxin by the addition of an anti-EpCAM sFv.
Stish BJ; Chen H; Shu Y; Panoskaltsis-Mortari A; Vallera DA
Clin Cancer Res; 2007 May; 13(10):3058-67. PubMed ID: 17505009
[TBL] [Abstract][Full Text] [Related]
39. Refined immunoRNases for the efficient targeting and selective killing of tumour cells: A novel strategy.
Nassiri M; Behnam-Rasouli R; Vakili-Azghandi M; Gopalan V; Dolati P; Nourmohammadi R
Life Sci; 2022 Jan; 289():120222. PubMed ID: 34902436
[TBL] [Abstract][Full Text] [Related]
40. Cytotoxic activities of recombinant immunotoxins composed of Pseudomonas toxin or diphtheria toxin toward lymphocytes from patients with adult T-cell leukemia.
Kreitman RJ; Chaudhary VK; Waldmann TA; Hanchard B; Cranston B; FitzGerald DJ; Pastan I
Leukemia; 1993 Apr; 7(4):553-62. PubMed ID: 8464234
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
